Evaluation of an Online Prostate Cancer Screening Decision Aid

Launched by DAVID SIEGEL · Sep 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying an online tool called "Talk to Nathan About Prostate Cancer Screening" to see if it helps men make better decisions about prostate cancer screening. The researchers want to find out if this online aid improves understanding, helps overcome challenges in understanding health information, and reduces confusion when deciding about screening compared to standard methods. They will also explore how to best use this tool in regular doctor visits.

To participate, men aged 55 to 69 who are scheduled for a health exam and have internet access can join the trial. Participants will use either the "Talk to Nathan" tool, a standard decision aid, or regular education materials about prostate cancer screening. They will visit their primary care clinic for follow-up and complete surveys during the trial. It's important to note that those with certain urinary symptoms, a history of prostate cancer, or other specific health issues may not be eligible. This trial is a great opportunity for eligible men to learn more about prostate cancer screening in an easy-to-understand way.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Male.
• • Aged 55-69 years.
• • Scheduled for an upcoming health exam.
• • Has access to the internet.
• • Has a valid email address or valid mobile phone number with SMS capabilities.
• • Speaks and reads English or Spanish.
• Exclusion Criteria:
• • Refuses to participate.
• • Currently has urinary tract symptoms (i.e., difficulty starting urination; weak or interrupted flow of urine; urinating often, especially at night; trouble emptying the bladder completely; pain or burning during urination; blood in the urine or semen; pain in the back, hips, or pelvis that doesn't go away; or painful ejaculation).
• • Prior history of prostate cancer.
• • Scheduled for, undergoing, or has had a prostate biopsy.
• • A previous PSA score is contained in the patient's health record and it is \> 3 ng/mL and/or a very suspicious digital rectal exam (DRE) result (defined as the presence of significant induration, nodularity, or asymmetry).
• • Patient has a terminal illness, significant psychiatric comorbidity (identified by clinic coordinator), cognitive deficits, or reports of ongoing substance misuse.